WHITEHAWK THERAPEUTICS, INC. Interest Payable, Current
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Interest Payable, Current of $483.44 thousand as of 2016-12-31, per its 10-K filed 2018-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2018-03-15
- 2016-12-31: Interest Payable, Current $483.44K; Interest Payable, Current as first filed $42.38K.
- 2016-09-30: Interest Payable, Current $39.81K.
- 2016-06-30: Interest Payable, Current $37.37K.
- 2016-03-31: Interest Payable, Current $34.83K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2016-12-31 | $483.44K 10-K · filed 2018-03-15 | $42.38K 10-K · filed 2017-03-07 |
| 2016-09-30 | $39.81K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $37.37K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $34.83K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $32.44K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $30.22K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $28.02K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $25.86K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $24.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $22.11K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $20.45K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $18.80K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $17.18K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $15.51K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $13.85K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $12.55K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $11.30K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $10.01K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $8.73K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $7.46K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $6.32K 10-K · filed 2013-03-28 | |
| 2010-12-31 | $2.72K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |